Clinical Trial Update: Lurasidone Extended Use Study [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 extended-use trial of lurasidone for schizophrenia and bipolar disorder, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Lurasidone (Latuda) (lurasidone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Schizophrenia, Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-03-11